- Home
- SONN vs SXTP Comparison
SONN vs SXTP Comparison
Compare SONN & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- SXTP
- Stock Information
- Founded
- SONN N/A
- SXTP 2010
- Country
- SONN United States
- SXTP United States
- Employees
- SONN N/A
- SXTP N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SONN Health Care
- SXTP Health Care
- Exchange
- SONN Nasdaq
- SXTP Nasdaq
- Market Cap
- SONN 2.5M
- SXTP 2.4M
- IPO Year
- SONN N/A
- SXTP 2023
- Fundamental
- Price
- SONN $1.62
- SXTP $0.58
- Analyst Decision
- SONN Strong Buy
- SXTP Hold
- Analyst Count
- SONN 2
- SXTP 1
- Target Price
- SONN $38.00
- SXTP N/A
- AVG Volume (30 Days)
- SONN 282.7K
- SXTP 4.3M
- Earning Date
- SONN 02-12-2025
- SXTP 03-31-2025
- Dividend Yield
- SONN N/A
- SXTP N/A
- EPS Growth
- SONN N/A
- SXTP N/A
- EPS
- SONN N/A
- SXTP N/A
- Revenue
- SONN $18,626.00
- SXTP $462,612.00
- Revenue This Year
- SONN N/A
- SXTP $141.35
- Revenue Next Year
- SONN N/A
- SXTP $175.16
- P/E Ratio
- SONN N/A
- SXTP N/A
- Revenue Growth
- SONN N/A
- SXTP 128.99
- 52 Week Low
- SONN $1.41
- SXTP $0.53
- 52 Week High
- SONN $18.72
- SXTP $7.20
- Technical
- Relative Strength Index (RSI)
- SONN 42.90
- SXTP 36.30
- Support Level
- SONN $1.64
- SXTP $0.75
- Resistance Level
- SONN $2.05
- SXTP $1.20
- Average True Range (ATR)
- SONN 0.17
- SXTP 0.12
- MACD
- SONN 0.03
- SXTP -0.02
- Stochastic Oscillator
- SONN 24.59
- SXTP 14.01
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.